Information to Improve Public Perceptions of the Food and Drug Administration (FDA’s) Tobacco Regulatory Role

Abstract

While the Food and Drug Administration (FDA) has had regulatory authority over tobacco products since 2009, public awareness of this authority remains limited. This research examines several broad types of information about FDA tobacco regulatory mission that may improve the perceptions of FDA as a tobacco regulator. Using Amazon Mechanical Turk, 1766 adults, smokers and non-smokers, were randomly assigned to view a statement about FDA regulatory authority that varied three information types in a 2 × 2 × 2 between subjects experimental design: (1) FDA’s roles in regulating tobacco (yes/no); (2) The scientific basis of regulations (yes/no); and (3) A potential protective function of regulations (yes/no). Using factorial ANOVA, we estimated the main and interactive effects of all three types of information and of smoking status on the perceptions of FDA. Participants that were exposed to information on FDA roles reported higher FDA credibility and a greater perceived knowledge of FDA than those who did not. Exposure to information about the scientific basis of regulations led to more negative views of the tobacco industry. Participants who learned of the FDA’s commitment to protecting the public reported higher FDA credibility and more positive attitudes toward regulations than those who did not learn of this commitment. We observed no significant interaction effects. The findings suggest that providing information about the regulatory roles and protective characterization of the FDA’s tobacco regulatory mission positively influence public perceptions of FDA and tobacco regulations.

Consumer understanding of the scope of FDA's prescription drug regulatory oversight: A nationally representative survey

“…Other recent findings suggest that providing more information about FDA's regulatory role can positively influence public perceptions of FDA and increase positive attitudes toward regulation . FDA currently has a multi‐faceted outreach program through which information is disseminated about FDA‐regulated products .…”

The importance of psychology for shaping legal cannabis regulation.

“….the ‘personality’ of the regulatory agency may matter more than the specific regulations” (Caulkins & Kilmer, 2016b). However, in order to shape social norms, a regulatory agency’s messages must be effective, and in order for its messages to be effective, an agency must be perceived as credible by the public (Osman et al, 2018; Pornpitakpan, 2004; Ranney et al, 2018; Schmidt et al, 2018; Schmidt, Ranney, Pepper, & Goldstein, 2016).…”

“…PSYCHOLOGY AND CANNABIS REGULATION agency must be perceived as credible by the public (Osman et al, 2018;Pornpitakpan, 2004;Ranney et al, 2018;Schmidt et al, 2018;Schmidt, Ranney, Pepper, & Goldstein, 2016).…”

E-Cigarettes and the Multiple Responsibilities of the FDA

“…4 (Carpenter 2010) A growing body of research establishes that such "organizational trust" is, in turn, "a key determinant of how well risk communications are processed and received by the public." 5 (Osman et al 2018) Understanding the public's right to be appropriately advised by the FDA is thus different from the public's right to information. While it is the duty of the FDA to not deceive the public or misrepresent the evidence, the guidance that the agency chooses to endorse on the basis of the evidence should be evaluated on both epistemic and ethical grounds.…”